Charles River Laboratories International, Inc.

CRLNYSE • USD
333.02 USD
↘ 4.95 (1.46%)🟢PRE MARKET (AS OF 09:10 AM EST)
🟢Market: OPEN

Shares of Charles River Laboratories International, Inc. (CRL) are trading at $333.02. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Buy" and "Buy" respectively. Notable factors include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$338.71
High?$338.71
Low?$333.00
Prev. Close?$337.97
Volume?192
Avg. Volume?1.2M
VWAP?$334.14
Rel. Volume?0.00x
Bid / Ask
Bid?$327.00 × 480
Ask?$337.37 × 80
Spread?$10.37
Midpoint?$332.19
Valuation & Ratios
Market Cap?16.2B
Shares Out?47.9M
Float?47.1M
Float %?98.8%
P/E Ratio?402.98
P/B Ratio?5.02
EPS?$0.84
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Employees
19.7K
Market Cap
16.2B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2000-06-23
Address
251 BALLARDVALE ST
WILMINGTON, MA 01887
Phone: 781-222-6000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
99
Momentum?
86
Short Sent.?
70
Piotroski F-Score?6/9Mixed
Altman Z-Score?5.35Safe
Confidence?78%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.34%Elevated
Short Interest?3.0M
Days to Cover?2.2
Free Float47.1M
Avg Daily Volume1.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.41Adequate
Quick Ratio?1.12Adequate
Cash Ratio?0.18Low
Debt/Equity?0.76Moderate
ValuationRICHLY VALUEDvs 6 peers + S&P 500
Score
50/100
P/E?
Peers
14
S&P
3
403.0PRICEY▾
P/B?
Peers
71
S&P
37
5.02FAIR▾
P/S?
Peers
86
S&P
37
4.07FAIR▾
P/FCF?
Peers
14
S&P
7
60.1PRICEY▾
EV/EBITDA?
Peers
86
S&P
19
22.5HIGH▾
EV/Sales?
Peers
86
S&P
39
4.64FAIR▾
Returns & Efficiency
ROE?
Peers
14
S&P
16
1.3%WEAK▾
ROA?
Peers
14
S&P
9
0.5%WEAK▾
Cash Flow & Enterprise
FCF?$269.4M
Enterprise Value?$18.4B
Fundamentals ratios updated end of day